[Federal Register Volume 89, Number 13 (Friday, January 19, 2024)]
[Notices]
[Page 3635]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00983]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-52-2023]


Foreign-Trade Zone (FTZ) 46; Authorization of Production 
Activity; Patheon Pharmaceuticals Inc.; (Pharmaceutical Products); 
Cincinnati, Ohio

    On September 18, 2023, Patheon Pharmaceuticals Inc. submitted a 
notification of proposed production activity to the FTZ Board for its 
facility within Subzone 46K, in Cincinnati, Ohio.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (88 FR 67230-67231, September 29, 
2023). On January 16, 2024, the applicant was notified of the FTZ 
Board's decision that no further review of the activity is warranted at 
this time. The production activity described in the notification was 
authorized, subject to the FTZ Act and the FTZ Board's regulations, 
including section 400.14.

    Dated: January 16, 2024.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2024-00983 Filed 1-18-24; 8:45 am]
BILLING CODE 3510-DS-P